Functional and structural plasticity is a fundamental property of the brain involving chemical, electrical, molecular and cellular responses and leading to reorganization of connections within a brain region and/or between brain regions. The Notch pathway has been recognized as one of the main contributors in regulating neural development and has been proposed as a key mediator in neuroplasticity. We supported this concept, demonstrating that Notch plays a role in determining the only possible ‘cell fate' decisions in post-mitotic mature neurons: synaptic remodelling or neurite extension/retraction. We demonstrated that Notch pathway activation causes a decrease in neurite branching and a loss of varicosities, with consequent reduction in the release of neurotransmitters. Furthermore, in dysfunctional neurons that present Notch pathway hyper-activation, neuronal morphology was reverted by Notch-inhibiting agents. Potentially, a better understanding of the molecular events participating in neuroplasticity may provide relevant information for innovative therapeutic approaches in a variety of neurological disorders. Hence, we propose a Notch-signalling fine-tuned manipulation as a novel approach to modulate neuronal cytoskeleton plasticity in order to prevent dysfunctional structural plasticity in neurodegenerative diseases.

1.
Cairns NJ, Lee VM, Trojanowski JQ: The cytoskeleton in neurodegenerative diseases. J Pathol 2004;204:438-449.
2.
Trojanowski JQ, Smith AB, Huryn D, Lee VM: Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments. Expert Opin Pharmacother 2005;6:683-686.
3.
Roy S, Zhang B, Lee VM, Trojanowski JQ: Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol 2005;109:5-13.
4.
Michaelis ML, Seyb KI, Ansar S: Cytoskeletal integrity as a drug target. Curr Alzheimer Res 2005;2:227-229.
5.
Nelson R: Microtubule-stabilising drugs may be therapeutic in AD. Lancet Neurol 2005;4:83-84.
6.
Louvi A, Artavanis-Tsakonas S: Notch signalling in vertebrate neural development. Nat Rev Neurosci 2006;7:93-102.
7.
Nikonenko I, Jourdain P, Muller D: Presynaptic remodeling contributes to activity-dependent synaptogenesis. J Neurosci 2003;23:8498-8505.
8.
Ferrari-Toninelli G, Bonini SA, Uberti D, Napolitano F, Stante M, Santoro F, Monopoli G, Zambrano N, Russo T, Memo M: Notch activation induces neurite remodeling and functional modifications in SH-SY5Y neuronal cells. Dev Neurobiol 2009;69:378-391.
9.
Trotta N, Orso G, Rossetto MG, Daga A, Broadie K: The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr Biol 2004;14:1135-1147.
10.
Eckert T, Le DT, Link S, Friedmann L, Woehlke G: Spastin's microtubule-binding properties and comparison to katanin. PLoS One 2012;7:e50161.
11.
Evans KJ, Gomes ER, Reisenweber SM, Gundersen GG, Lauring BP: Linking axonal degeneration to microtubule remodeling by spastin-mediated microtubule severing. J Cell Biol 2005;168:599-606.
12.
Eckert T, Link S, Le DT, Sobczak JP, Gieseke A, Richter K, Woehlke G: Subunit interactions and cooperativity in the microtubule-severing AAA ATPase spastin. J Biol Chem 2012;287:26278-26290.
13.
Ferrari-Toninelli G, Bonini SA, Bettinsoli P, Uberti D, Memo M: Microtubule stabilizing effect of notch activation in primary cortical neurons. Neuroscience 2008;154:946-952.
14.
Verhey KJ, Gaertig J: The tubulin code. Cell Cycle 2007;6:2152-2160.
15.
Goedert M, Jakes R, Vanmechelen E: Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995;189:167-169.
16.
Van Uden E, Mallory M, Veinbergs I, Alford M, Rockenstein E, Masliah E: Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein. J Neurosci 2002;22:9298-9304.
17.
Bonini SA, Ferrari-Toninelli G, Uberti D, Montinaro M, Buizza L, Lanni C, Grilli M, Memo M: Nuclear factor κB-dependent neurite remodeling is mediated by Notch pathway. J Neurosci 2011;31:11697-11705.
18.
Lu ZY, Yu SP, Wei JF, Wei L: Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice. Neuroscience 2006;139:965-978.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.